Skip to main content
Loading

Carina Biotech

October 18, 2023
Franciscan B
Gene/Cell Therapy
Company Description: Carina Biotech is a private Australian immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. CAR-T therapy is a revolutionary new treatment option that uses a patient's immune system to fight their cancer. Carina has a pipeline of novel CAR-T programs for the treatment of a range of solid cancers, with the lead program targeting LGR5, a cancer stem cell marker in Phase 1 for the treatment of metastatic colon cancer. The company has also developed a proprietary multi-functional chemokine receptor platform to enable CAR-T cell arming, homing and access to tumors and an efficient CAR-T cell manufacturing platform to increase efficacy through serial cancer cell killing and persistence within tumors.
Speakers
Deborah Rathjen, CEO - Carina Biotech